CN106617106A - Nutritional supplement capable of delaying senescence - Google Patents
Nutritional supplement capable of delaying senescence Download PDFInfo
- Publication number
- CN106617106A CN106617106A CN201611177806.3A CN201611177806A CN106617106A CN 106617106 A CN106617106 A CN 106617106A CN 201611177806 A CN201611177806 A CN 201611177806A CN 106617106 A CN106617106 A CN 106617106A
- Authority
- CN
- China
- Prior art keywords
- protein
- echinacea
- tobacco
- nutritious supplementary
- supplementary pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015872 dietary supplement Nutrition 0.000 title abstract 4
- 230000009758 senescence Effects 0.000 title abstract 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims abstract description 67
- 235000014134 echinacea Nutrition 0.000 claims abstract description 64
- 244000133098 Echinacea angustifolia Species 0.000 claims abstract description 62
- 241000208125 Nicotiana Species 0.000 claims abstract description 56
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 55
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 53
- 150000004676 glycans Chemical class 0.000 claims abstract description 41
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 39
- 239000005017 polysaccharide Substances 0.000 claims abstract description 39
- 235000008935 nutritious Nutrition 0.000 claims description 25
- 235000013305 food Nutrition 0.000 claims description 22
- 230000003712 anti-aging effect Effects 0.000 claims description 14
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 9
- 230000036541 health Effects 0.000 claims description 8
- 239000005711 Benzoic acid Substances 0.000 claims description 6
- 235000010233 benzoic acid Nutrition 0.000 claims description 6
- 239000000796 flavoring agent Substances 0.000 claims description 6
- 235000019634 flavors Nutrition 0.000 claims description 6
- 108010011485 Aspartame Proteins 0.000 claims description 5
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical group OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 5
- 229960003438 aspartame Drugs 0.000 claims description 5
- 235000010357 aspartame Nutrition 0.000 claims description 5
- 239000000605 aspartame Substances 0.000 claims description 5
- 239000000654 additive Substances 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000001814 pectin Substances 0.000 claims description 4
- 235000010987 pectin Nutrition 0.000 claims description 4
- 229920001277 pectin Polymers 0.000 claims description 4
- 239000002562 thickening agent Substances 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 239000003292 glue Substances 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 230000032683 aging Effects 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 4
- 239000013589 supplement Substances 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 235000018102 proteins Nutrition 0.000 description 48
- 241000699666 Mus <mouse, genus> Species 0.000 description 21
- 230000000694 effects Effects 0.000 description 18
- 238000000034 method Methods 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 108090000765 processed proteins & peptides Proteins 0.000 description 16
- 238000011160 research Methods 0.000 description 16
- 239000000047 product Substances 0.000 description 13
- 101710138460 Leaf protein Proteins 0.000 description 12
- 244000061176 Nicotiana tabacum Species 0.000 description 11
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 11
- 239000002253 acid Substances 0.000 description 11
- 229910052711 selenium Inorganic materials 0.000 description 11
- 239000011669 selenium Substances 0.000 description 11
- 229940091258 selenium supplement Drugs 0.000 description 11
- 241000196324 Embryophyta Species 0.000 description 10
- 235000019504 cigarettes Nutrition 0.000 description 9
- 238000012546 transfer Methods 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- 241000287828 Gallus gallus Species 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 230000001376 precipitating effect Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 239000012467 final product Substances 0.000 description 7
- 238000003304 gavage Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 101100341609 Drosophila melanogaster jing gene Proteins 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 210000000822 natural killer cell Anatomy 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 240000004530 Echinacea purpurea Species 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 108010074686 Selenoproteins Proteins 0.000 description 4
- 102000008114 Selenoproteins Human genes 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000222122 Candida albicans Species 0.000 description 3
- 108020004635 Complementary DNA Proteins 0.000 description 3
- 102100040247 Tumor necrosis factor Human genes 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 229940095731 candida albicans Drugs 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 108010083391 glycinin Proteins 0.000 description 3
- WFKAJVHLWXSISD-UHFFFAOYSA-N isobutyramide Chemical compound CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 240000005250 Chrysanthemum indicum Species 0.000 description 2
- YDDGKXBLOXEEMN-UHFFFAOYSA-N Di-E-caffeoyl-meso-tartaric acid Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC(C(O)=O)C(C(=O)O)OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-UHFFFAOYSA-N 0.000 description 2
- 108010016626 Dipeptides Proteins 0.000 description 2
- 108010003272 Hyaluronate lyase Proteins 0.000 description 2
- 102000001974 Hyaluronidases Human genes 0.000 description 2
- -1 INF- α Proteins 0.000 description 2
- 108010002352 Interleukin-1 Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000003957 anion exchange resin Substances 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- YDDGKXBLOXEEMN-IABMMNSOSA-N chicoric acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000006193 cichoric acid Nutrition 0.000 description 2
- 229930016920 cichoric acid Natural products 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- YDDGKXBLOXEEMN-WOJBJXKFSA-N dicaffeoyl-L-tartaric acid Natural products O([C@@H](C(=O)O)[C@@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-WOJBJXKFSA-N 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- 238000012869 ethanol precipitation Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 229960002773 hyaluronidase Drugs 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 238000005360 mashing Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical class OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- DLBZXSBRTZLLKR-OWOJBTEDSA-N 2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enyl]-2,3-dihydroxybutanedioic acid Chemical compound OC(=O)C(O)C(O)(C(O)=O)C\C=C\C1=CC=C(O)C(O)=C1 DLBZXSBRTZLLKR-OWOJBTEDSA-N 0.000 description 1
- KDSNLYIMUZNERS-UHFFFAOYSA-N 2-methylpropanamine Chemical class CC(C)CN KDSNLYIMUZNERS-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 102100027211 Albumin Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000004452 Arginase Human genes 0.000 description 1
- 108700024123 Arginases Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 108010049994 Chloroplast Proteins Proteins 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 201000007336 Cryptococcosis Diseases 0.000 description 1
- 241000221204 Cryptococcus neoformans Species 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 101000620009 Homo sapiens Polyunsaturated fatty acid 5-lipoxygenase Proteins 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241000702626 Infectious bursal disease virus Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 102100026720 Interferon beta Human genes 0.000 description 1
- 108090000467 Interferon-beta Proteins 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000186779 Listeria monocytogenes Species 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 241000187480 Mycobacterium smegmatis Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 208000035823 Non-specific autoimmune cerebellar ataxia without characteristic antibodies Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 102100022364 Polyunsaturated fatty acid 5-lipoxygenase Human genes 0.000 description 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 241000223598 Scedosporium boydii Species 0.000 description 1
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 238000003483 aging Methods 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical group O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000884 anti-protozoa Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 210000001669 bursa of fabricius Anatomy 0.000 description 1
- DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 description 1
- 230000003185 calcium uptake Effects 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 229940117173 croton oil Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229940045811 echinacea purpurea extract Drugs 0.000 description 1
- 229940016126 echinacea root extract Drugs 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 108060002894 fibrillar collagen Proteins 0.000 description 1
- 102000013373 fibrillar collagen Human genes 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000002035 hexane extract Substances 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 238000003859 hyphenated technique Methods 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000007124 immune defense Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229940047889 isobutyramide Drugs 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000000610 leukopenic effect Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013384 milk substitute Nutrition 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000004526 pharmaceutical effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 229940108461 rennet Drugs 0.000 description 1
- 108010058314 rennet Proteins 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Chemical compound [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 1
- 229960002718 selenomethionine Drugs 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000003104 tissue culture media Substances 0.000 description 1
- 238000012090 tissue culture technique Methods 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- SWGKAHCIOQPKFW-UHFFFAOYSA-N trans-caffeoyl-tartaric acid Natural products OC(=O)C(O)C(C(O)=O)OC(=O)C=CC1=CC=C(O)C(O)=C1 SWGKAHCIOQPKFW-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 235000021081 unsaturated fats Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 229960003487 xylose Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention relates to a nutritional supplement capable of delaying senescence. The active ingredients of the supplement include 80-20wt% of tobacco protein and 20-80wt% of echinacea polysaccharide. Compared with a traditional nutritional supplement, the nutritional supplement provided by the invention has the advantages of being simple in preparation method and reasonable in compatibility, and two active ingredients can work together to improve the ageing speed of a body while developing respective efficacies.
Description
Technical field
The present invention relates to food and field of health care products, and in particular to a kind of nutritious supplementary pharmaceutical.
Background technology
With the raising of living standards of the people, the public is increasingly strong to nutrition and the requirement of health, containing various in food
Nutrient, but because species is different, its distribution is also differed with content.Additionally, in the production, processing and preserving process in food,
Nutrient often suffers a loss.For the deficiency of nutrient in supplement, nutritive value of food is improved, adapt to different crowd
Need, nutrition fortifier can be added.Nutrition fortifier has simplified meals concurrently and processes, conveniently ingests and disease-prevention health etc. is acted on.It is special
Not current, food nutrient fortifying has become the important means that many national governments improve its commonwealth general level of the health.
Presently commercially available nutritious supplementary pharmaceutical mostly is inorganic molecules compound, and these compounds are mainly obtained by chemical synthesis
.Researcher constantly looks for originating natural, effect significantly, particularly the nutritious supplementary pharmaceutical with delaying senility function.
In tobacco leaf numerous compositions, enriched the most with protein content.Protein in tobacco leaf be divided into soluble protein and
Insoluble protein.Half or so is chloroplast protein in soluble protein(Fraction I protein, FI albumen), separately
Half is the compound of other soluble proteins(Fraction II protein, F II albumen).In the past people were mostly
Concentrate on the protein content for improving crop fructification, less focus on the exploitation of plant leaf protein.With
And leaf protein research is deepened continuously, people gradually recognize that plant leaf protein is protein resource most abundant in the world, are
Solve a new food proteins source of our times population increasingly expansion issues.
Some results of study show that plant leaf protein is especially high with soluble protein content in tobacco leaf, in FI albumen
Various essential amino acids contents are not only above essential amino acids content standard in the protein product of the World Food Programme's formulation, its
Middle tyrosine, phenylalanine, threonine and leucine are above 1 times or so of the standard, than some staple food crops such as paddy rice,
Essential amino acids content in wheat, corn and soybean protein is all high, shows that FI albumen has higher nutriture value in tobacco leaf
Value.Tobacco leaf protein matter is more suitable for absorption of human body and utilizes than egg, cheese and milk, with higher nutritive value and medicinal valency
Value.
The FI albumen that early stage research worker extracts is often with color and taste, and complex manufacturing, and investment is big, produces
Amount is low, and people are difficult to receive.Later, many researchers were purified to the FI albumen in tobacco leaf, had obtained high-purity
FI albumen, the progressively simplification of wherein Kung and Tso, Lowe to tobacco leaf FI protein purification methods is made that very big contribution.So
And, these extracting methods have hypervelocity or at a high speed freezing step with centrifugal separation, and mostly process is both needed to control at 0-4 DEG C or so;
Also have and FI albumen is extracted using methods such as isoelectric focusing, gel electrophoresis, ultrafiltration.Although these methods can obtain pure FI eggs
In vain, but relatively costly, the yield that the unit interval extracts is relatively low, it is difficult to realize large-scale industrial production.The extraction skill of FII albumen
Art is simpler than FI albumen a lot, and further investigation has been also carried out both at home and abroad, and has had been enter into the application stage, and such as tobacco leaf selenoprotein is made
For food additives and health food in China's field of food extensive application.
Tobacco leaf protein in addition to the basic function characteristic with protein, also with many special functional characteristics.Tobacco leaf
Selenium is rich in albumen, is existed with selenomethionine and selenocystein or other forms.Selenium has extensive medical care effect, mends
The pre- anti-cancer of selenium energy, hepatitis, angiocardiopathy etc. are filled, selenium prevents leukopenic effect to the chemotherapy of cancer patient.So
And, selenium is again the trace element of nutrition dosage and toxicity dose narrow range, therefore, selenium of the development with the efficient attribute of low toxicity is produced
Product are significant with therapy-related disease for preventing.Using metabolism of the tobacco leaf to inorganic selenium, protein state selenium is obtained;Nothing
During protein state selenium is converted into, toxicity is substantially reduced machine selenium, is mainly shown as declining to a great extent for acute toxicity.It is existing
Ample evidence shows, compared with sodium selenite, tobacco leaf selenoprotein has low toxicity high-efficient characteristic, thus tobacco leaf selenoprotein is used as new
Selenium source has potential advantages.At present, tobacco leaf selenoprotein is by the approval of the Ministry of Public Health of China as food additives and with immunity tune
Section, the health food of function of delaying senility.The combustion product of tobacco leaf protein has a negative impact to the suction taste of cigarette, thus from cigarette
Tobacco leaf protein is extracted in leaf, remaining part is used for into production of cigarettes, will be the developing direction of tobacco comprehensive utilization.
Tobacco leaf protein obtains various biologically active peptides Jing after enzyme hydrolysis.These peptides can be small enough to only 2 ammonia
The dipeptides of base acid, or the long-chain or ring type polypeptide of complexity, and be mostly through glycosylation, phosphorylated derivatives products
Thing.Modern biotechnology metabolism research finds:The protein of human consumption after gastral various enzyme hydrolysis, unlike having previously been thought that
As absorbed only in the form of amino acid, be more directly to be absorbed in the form of low peptide, and dipeptides and tripeptides
Infiltration rate than same composition amino acid faster.Recent studies indicate that:Biologically active peptide is a class multifunctional agents, raw
The growing of thing, cell differentiation, brain activity, neoplastic lesion, immune defense, reproduction control, anti-aging, biological clock rule and
Molecular evolution etc. all refers to biologically active peptide.A class bioactive micro peptide such as antibacterial active peptide, typically have antibacterium or
The effect of fungi, some also have the function of antiprotozoan, virus or tumour cell.Antibacterial peptide has the antibacterial action of wide spectrum, right
Gram-positive bacteria, Gram-negative bacteria, fungi are respectively provided with inhibitory action;The tumour cell in animal body can also be killed, but
The normal cell not destroyed in animal body.And for example blood pressure lowering peptide, is have the one of notable hypotensive activity after native protein hydrolysis
Class peptide, Long-Time Service also has no toxic side effect.Blood pressure lowering peptide is mainly by the angiotensin-converter in Reverse transcriptase human body
Enzyme activity and reach hypotensive purpose.The tridecanoic peptide extracted from tobacco leaf protein, presses down with antibacterial activity and protease
System activity, and be a kind of potential protease inhibitors with higher stability.
At present, it is special about being rarely reported by the research country that raw material produces biologically active peptide and amino acid of tobacco protein
It is not to prepare biologically active peptide aspect, foreign countries also seldom report.And say from food and the angle of nutrition, with biologically active peptide as work(
The energy factor, can develop low antigen food, baby food, sports food, rush calcium uptake food, blood pressure-reducing food, sobering food
Etc. a series of products.
Plant physiologist thinks, tobacco leaf protein it is best in quality, many containing amino acid classes, be most easily absorbed by the body profit
With;And per 667m2Well-grown tobacco, can extract out the protein of 35kg colorless and odorless.Tobacco protein both can be diluted to
Albumin, can be processed into cake, margarine and the cows milk substitute of various delicious foods again, such as select halogen, become again delicate
Tobacco leaf bean curd.In ice conditions, soft cream is can be made into, compared with animality cream in the market, this cream has
Two big prominent advantages:1. it is many containing unsaturated fat;2. quantity of heat production is low, and more food will not be fat.In addition, tobacco protein also has growing
Ease constipation stomach and the effects such as stimulate circulation.
Using interior circumscribed albumen complex enzyme, tobacco leaf protein is carried out into Controlled-enzymatic Hydrolysis process, according to the difference of its Degree of Enzymatic Hydrolysis,
A series of biologically active peptides and amino acid can be obtained.Using classification membrane separation technique, classification UF membrane and macroporous resin adsorption
Separation or ion exchange resin separation GC-MS are isolated and purified, enrichment method target product, then the corresponding working processes of Jing, can be made
Obtain a series of functional foods;Be there is into Maillard reactions in the enzymolysis liquid of discarded tobacco leaf and reduced sugar, alcohol etc., can synthesize and have
Strong fruital, nut are fragrant, bake the cigarette that perfume, paste flavor, Chinese herbal medicine are fragrant or tobacco is fragrant uses and flavorant, and these spices can improve cigarette
The aroma quality of silk, increases perfume quantity, mitigates the miscellaneous gas and excitant of cigarette, makes smoke alcohol and full, and can coordinate cigarette perfume, improves
Pleasant impression, for the perfuming of high, middle-grade cigarette, can strengthen the fine quality of high, middle-grade cigarette.
The cDNA of glycinin is transferred to into tobacco gene group Agrobacterium-mediated
In transformation, glycinin is expressed in tobacco seed, and is occurred in a kind of special mode.With it is big
Globulin in beans is compared, and resulting transgene tobacco glycinin is in protein expression level, processing characteristics, active work(
Can be with no significant difference on accumulating level.
Test data shows, tobacco be for producing medical treatment and scientific research in terms of collagen recombinant product it is most valuable
The raw material of value.Collagen accounts for the 30% of its total protein in mammalian body, and its main component is fibrillar collagen matter I-III, this
A little collagens constitute the crossed fiber network structure of extracellular matrix albumen, have very important effect in human body.Will
Tobacco is used to produce collagen restructuring series of products, can not only solve the raw material difficult problem that collagen product is produced in medicine and pharmacology, also
Be conducive to the raising of medical technique level, promote the further development of medical industry.
Research finds there is special cDNAs in the nectary of tobacco.CDNAs can encode out special plant rennet, this
The function that protease has opposing microorganism infringement is planted, so as to protect whole plant from infringement.How sharp currently study
With transgenic technology, carry out this special cDNAs transgenosis and process, realization carries out corresponding gene table in other plant
Reach, then this plant can just resist corresponding microorganism infringement, strengthen the defencive function of itself, so as to reduce the use of agricultural chemicals
Amount, reduces the residues of pesticides of agricultural product, while also mitigating the pollution to natural environment.
Echinacea(Echinacea), also known as genus echinacea or Echinacea, it is perennial composite family draft flowering plant,
Originate in central North America and east.At present, the category has found altogether 9 kinds and 2 mutation, wherein 3 kinds have medical value, i.e.,
Echinacea(Echinacea purpurea), narrow leaf Echinacea(Echinacea augustifolia)And white Echinacea
(Echinacen pallida).Echinacea is distributed widely in the U.S., Canada and Europe.In recent years, China successfully introduces a fine variety purple cone
Chrysanthemum, has plantation on Shaanxi, Henan, Hunan and other places.The plant is used to treating wound, toothache, snake and stings by iroquois people earliest
Wound and septicopyemia etc., are then used to prevent and treat the illnesss such as upper respiratory disease, skin disease and anaphylactia at present.Echinacea has
There are various efficient bio-actives such as immunological regulation, anti-inflammatory, anti-oxidant, sterilized, antiviral and anticancer, thus receive much concern.
Immunoregulatory activity is that Echinacea is most important, the biologically active for also attracting most attention, including following several respects:(1)
Promote the growth and development of immune organ.Research discovery, Echinacea Purpurea Herb P.E(Echinacea purpurea extract, EE)
The quality of mouse spleen can be significantly improved.According to the literature, compound Echinacea can significantly improve chicken bursa of Fabricius, thymus gland and spleen
Dirty index, promotes Development of Immune Organs.Test proves that EE significantly improves the Immune Organs Index of AA Broiler chicks.(2)Improve blood
Immunologic function and biochemical indicator.EE can not only improve mice serum immunoglobulin level and reduce total cholesterol level,
And can improve the red blood cell RBG-C of broiler chicken3BR rosette rates and serum proleulzin and TNF Contents, additionally it is possible to
Improve routine blood indexes.Echinacea compound can improve total protein and albuminous content in Lingnanhuang broilers blood plasma, reduce sweet
Oily three ester levels.(3)Adjust the function and propagation of immunocyte.EE can either remarkably promote normal mouse marrow and spleen nature
Cell and monocytic propagation are killed, also increases the quantity of leukemia mouse spleen NK cells, be also remarkably improved broiler chicken NK
The killing ability of cell.Research finds that EE is capable of the propagation of obvious stimulation T lymphocyte, and Cytokines in Peripheral Blood Mononuclear
Propagation also have facilitation.EE can activating macrophage, strengthen its phagocytic activity and stimulate its produce IL-1, IL-10 and
The cell factors such as TNF-a and nitric oxide.(4)Strengthen humoral immunity.Research shows that EE can significantly improve broiler chicken peripheral blood
IBDV and NDV antibody titer, and compound Echinacea also has significantly enhancing to the NDV antibody titers of sea blue Baigong chicken
Effect.(5)Other.Many acids in Echinacea also have preventive protection to act on stress in rats gastric ulcer, and may
It is relevant with raising immunity of organisms and enhancing NO synzyme vigor.Echinacea can also improve the word material conversion ratio of livestock and poultry, so as to change
Kind production performance.
It was discovered by researchers that the polysaccharide component of narrow leaf Echinacea has anti-inflammatory activity, it can suppress carrageenan to induce
Mouse podedema and croton oil induction mice auricle swelling.It is reported that, a kind of isobutylamides in Echinacea-
Dodecatetraenoic acid, can play antiinflammatory action by suppressing LOX.Proved by vitro test, in EE
Alkylamide material can suppress cyclooxygenase and 5- LOXs.EE can also suppress mouse macrophage prostaglandin
The generation of E2.Cichoric acid is considered as the material that can most suppress hyaluronidase in Echinacea.And hyaluronidase can be hydrolyzed
Bright matter acid and chondroitin, promote proinflammatory factor to pass through matrix, expand inflammatory reaction.Research shows that the scorching effect of suppression of Echinacea is also
It is relevant with suppressing huge saliva cell to produce NO and TNF-a.And further study and point out, Echinacea is to the inhibitory action that NO synthesizes
By improving arginase activities, and induced NOS is suppressed to express.
Document report, three kinds of medicinal Echinaceas(Echinacea purpurea、Echinacea augustifolia、
Echinacen pallida)Root extract various free radicals are respectively provided with Scavenging activity, and people's low-density lipoprotein can be suppressed
White oxidation.Confirm that above-mentioned three kinds medicinal Echinacea leaves and root are extracted by radicals scavenging experiment and lipid peroxidation experiment
The oxidation resistance of thing.Research finds that the caffeic acid derivative in EE has a good antioxidation, and with EE other into
When point being used in combination, antioxidant effect is higher.Result of study shows, EE samples prepared by three kinds of methods(Many acid contents are respectively
3.76%、6.40%、33.56%)It is respectively provided with antioxidation, and their reducing power and to H2O2Scavenging action be better than
Vitamin C.EE not only itself has certain antioxidation, and can strengthen the oxidation resistance of animal body.Research
Show, EE can strengthen the oxidation resistance of mouse and AA Broiler chicks.
Research finds that the polysaccharide component in Echinacea cells and supernatant can strengthen cytophagous function, so as to
Play a protective role during mouse infection Candida albicans and Listeria monocytogenes.Scientific research personnel has found that Echinacea is just
Oneself burns extract and has antifungal activity, can suppress the growth of brewer's yeast and various candida albicans.Research shows, genus echinacea
Root extract is to Cryptococcus neoformans, Candida albicans and various pathogenic filamentous fungis, such as trichophyta, beard and hair hair addiction
The little robe bacterium of bacterium, gypsum sample, Pseudoallescheria boydii have antifungal activity.In addition to above-mentioned fungi, EE is also to other various causes
Sick bacterium, such as micrococcus scarlatinae, haemophilus influenzae, legionella pneumophilia, clostridium difficile and propionibacterium acnes, golden yellow Portugal
Grape coccus, mycobacterium smegmatis are inhibited.
It is reported that, EE can increase leukemia mouse spleen NK cell quantities and extend its life-span.The anticancer of Echinacea is made
With mainly related to NK cells into close:On the one hand, the alkylamide material of Echinacea can pass through to suppress 5-LOX's and COX
Produce, the generation of PG is lowered, so as to promote the propagation of NK cells;On the other hand, the Arabic gala in Echinacea polysaccharide component
Glycan induces the cell factors such as its secretion IL-1, INF- α, IFN-β, so as to strengthen the thin of NK cells by activating macrophage
Born of the same parents kill ability.EE is not only able to wave antitumaous effect by NK iuntercellular sending and receiving, and itself also being capable of direct killing cancer cell.Examination
Issue after examination and approval now, the hexane extract of echinacea root is equal to human pancreas cancer MIA PACA-2 clones and colon cancer COLO320 clone
There is lethal effect.
Research shows that the various biologically actives of Echinacea are based on its own different chemical composition.At present, EE is by liquid phase color
The active component that spectrum mass spectrometric hyphenated technique is identified, mainly there is alkylamide compound and the big class of caffeic acid derivative two:Before
Person includes 12 carbon -2E, 4E, 8Z, 10E/Z- tetraenoic acid isobutyramide, 11 carbon -2E, 4Z- diene -8,10- diacetylenic acid isobutyls
Acid amides, 11 carbon -2Z, 4E- diene -8,10- diacetylenic acid isobutyramides, 11 carbon -2E, 4Z- diene -8,10- diacetylenic acid -2- first
Base butyramide etc.;The latter includes Cichoric acid, monocaffeyltartaric acid, chlorogenic acid, coffee sigh acid etc., and the polysaccharide in EE is mainly by mountain
Pears sugar, mannose, arabinose, rhamnose, galactolipin, 6 kinds of monose compositions of wood sugar.
It is isolated with immunocompetent two kinds of polysaccharide, PS from the aerial part of Echinacea Echinacea purpurea
I and PS II, its structure is respectively:4-O- methyl-grape alditol-arabinose-xylan glycan(Mean molecule quantity is
35000)With acid arabinose-sandlwood galactolipin glycan(Mean molecule quantity is 50000).Due to extracting pure from Echinacea
Change polysaccharide is costly and is difficult to obtain, therefore someone is separated with tissue culture technique from tissue culture medium, obtains 2 points
The acidic polysaccharose that son amount is respectively 10000,25000 neutral polysaccharide and 1 molecular weight is 75000, obtains from tissue cultures
Polysaccharide be mainly the primary wall composition of cultured cells, therefore different from polysaccharide detached from plant, its activity is also variant.
At present, there is not been reported for the application for combining with Echinacea polysaccharide for nutritional supplementation by tobacco protein.
The content of the invention
The technical problem to be solved is to provide one kind can effectively delay body aging, have no toxic side effect, activity
The natural nutritious supplementary pharmaceutical of ingredient origin.
The present invention the adopted technical scheme that solves the above problems is to provide a kind of nutritious supplementary pharmaceutical of anti-aging, mends
Fill active component in agent to be made up of tobacco protein and Echinacea polysaccharide, the percentage by weight that wherein tobacco protein accounts for active component is
80-20%, it is 20-80% that Echinacea polysaccharide accounts for the percentage by weight of active component.
Preferably, the percentage by weight that tobacco protein accounts for active component is 80-50%, and Echinacea polysaccharide accounts for active component
Percentage by weight is 20-50%.
It is furthermore preferred that the percentage by weight that tobacco protein and Echinacea polysaccharide account for active component is respectively 75% and 25%.
Preferably, the tobacco protein is tobacco FI albumen(Fraction I protein).
Preferably, tobacco FI albumen of the invention(Fraction I protein)Prepared using following methods:In removing
The Nicotiana tabacum leaves of arteries and veins, add NaCl solution, anion exchange resin and thin base ethanol, are smashed to pieces at a high speed with tissue mashing machine, green
Homogenate filtered through gauze.By filtrate in 50 DEG C of insulations, then cool down rapidly, discard precipitation.Supernatant passes through DEAE- celluloses
Post, with trichloroacetic acid protein is detected, and collects albumen part.Tris-Cl buffer solutions are added to the albumen part collected, in 4
DEG C place 4-6 days after separate out mass crystallization, obtain final product.
Preferably, Echinacea polysaccharide of the invention is prepared using following methods:The Echinacea herb raw material of ultramicro grinding is taken,
Add water and boil, extract clear liquid;Concentrate after activated carbon decolorizing, then use ethanol precipitating;Precipitating thing is centrifuged to obtain;By the drying of precipitating thing, grind
Grind, sieve, obtain Thick many candies;Thick many candies add water and are sufficiently stirred for, and filter at 4 DEG C, and supernatant is taken after centrifugation;Add Sevage reagents
Removing protein is removed, upper liquid is concentrated, with ethanol precipitation polysaccharide is separated out, Jing centrifugations obtain precipitating thing;Precipitating thing is washed with ethanol, very
Sky is dried, grinding, obtains the material of white powder.
Preferably, the composition further includes acceptable additive on food or health products.
It is furthermore preferred that the one kind of acceptable additive in preservative, thickener and flavor enhancement etc. on the food
Or it is various.
Most preferably, the preservative is benzoic acid;Thickener is pectin or gelatin, preferably pectin;Flavor enhancement be Ah
This Ba Tian.
The present invention also provides a kind of application of above-mentioned nutritious supplementary pharmaceutical in the food or health products for preparing anti-aging.
The invention has the advantages that:It is surprising that through repeated tests, present inventors have unexpectedly found that
Tobacco protein and Echinacea polysaccharide are applied in combination the effect for having Synergistic for body anti-aging.Mend with conventional nutraceutical
Fill agent to compare, the replenishers preparation method of the present invention is simple, rationally, two kinds of active components is playing the same of respective effect to compatibility
When, and can cooperate with and improve body aging speed.
Specific embodiment
The present invention is further described with reference to embodiment, but embodiments of the present invention not limited to this.
Preparation example 1, tobacco FI albumen(Fraction I protein)Preparation
Take 130 grams of Nicotiana tabacum leaves for going middle arteries, add the NaCl solution of 130g 0.1M, 30 gram of 711 anion exchange resin and
1ml dredges base ethanol, is smashed to pieces half a minute at a high speed with tissue mashing machine, and green homogenate is with four layers of filtered through gauze.By filtrate in 50 DEG C
Insulation 10 minutes, then cools down rapidly, discards precipitation.By DEAE- cellulose column DE53, flow velocity is 1.0ml/min/ to supernatant
cm3.Protein is detected with trichloroacetic acid, the albumen part for flowing out is collected.Equal-volume 0.025M is added to the albumen part collected
Tris-Cl, pH 7.4 includes the buffer solution of 0.2mM EDTA.Mass crystallization is separated out after placing 6 days in 4 DEG C, is obtained final product.Jing converts,
About 7mg/ gram fresh weight leaf of crystal yields.
The preparation of preparation example 2, Echinacea polysaccharide
The Echinacea herb raw material of ultramicro grinding is taken, adds the water of 20 times of amounts, heating to boil 3 hours, filter impurity, extract clear
Liquid;Jing activated carbon decolorizings again;Liquid is concentrated after decolouring, then uses ethanol precipitating;Precipitating thing is obtained using centrifugal method;Again will
Precipitating thing is dried, ground, crosses 60 mesh sieves, obtains Thick many candies;Thick many candies add water and are sufficiently stirred for, and filter at 4 DEG C, take after centrifugation
Clear liquid;Add Sevage reagents to remove removing protein, upper liquid is concentrated, with 5 times of amount ethanol precipitations polysaccharide is separated out, Jing centrifugations are sunk
Analysis thing;Washed with ethanol again 2 times, be vacuum dried, grinding obtains the material of white powder.
Experimental technique used in following embodiments 1-5 and test example 1 if no special instructions, is conventional method, makes
Raw material tobacco protein and Echinacea polysaccharide are respectively tobacco FI albumen and Echinacea polysaccharide obtained in preparation example 1 and 2.
Embodiment 1
The tobacco protein of 3 weight portions and the Echinacea polysaccharide of 1 weight portion are weighed, is poured into after both are mixed in mixer and is stirred 10
Minute, dispense as requested, it is packaged into packed, obtain final product anti-aging nutritious supplementary pharmaceutical.
Embodiment 2
The tobacco protein of 30 weight portions and the Echinacea polysaccharide of 10 weight portions are weighed, it is bright with 50 weight portions after both are mixed
The benzoic acid of glue, the Aspartame of 5 weight portions and 5 weight portions is together poured in mixer and stirred 15 minutes, is dispensed as requested,
It is packaged into packed, obtains final product the nutritious supplementary pharmaceutical of anti-aging.
Embodiment 3
The tobacco protein of 10 weight portions and the Echinacea polysaccharide of 30 weight portions are weighed, with the fruit of 50 weight portions after both are mixed
The benzoic acid of glue, the Aspartame of 5 weight portions and 5 weight portions is together poured in mixer and stirred 15 minutes, is dispensed as requested,
It is packaged into packed, obtains final product the nutritious supplementary pharmaceutical of anti-aging.
Embodiment 4
Weigh the tobacco protein of 8 weight portions and the Echinacea polysaccharide of 32 weight portions, after both are mixed with the gelatin of 50 weight portions,
The benzoic acid of the Aspartame of 5 weight portions and 5 weight portions is together poured in mixer and stirred 15 minutes, is dispensed as requested, is wrapped
Dress up packed, obtain final product the nutritious supplementary pharmaceutical of anti-aging.
Embodiment 5
Weigh the tobacco protein of 32 weight portions and the Echinacea polysaccharide of 8 weight portions, after both are mixed with the pectin of 50 weight portions,
The benzoic acid of the Aspartame of 5 weight portions and 5 weight portions is together poured in mixer and stirred 15 minutes, is dispensed as requested, is wrapped
Dress up packed, obtain final product the nutritious supplementary pharmaceutical of anti-aging.
The application of test example 1, the nutritious supplementary pharmaceutical containing tobacco protein/Echinacea polysaccharide in mice age is delayed
1. animal packet and administration
70 mouse are divided into at random 7 groups:Blank group, model group and medicine group A1-A5 of the present invention.Standard feed point cage is raised
Support, free diet drinking-water is tested after raising 1 week.Medicine group A1-A5 is given with the normal saline solution gavage of active component
Medicine, the accumulated dose of active component is 1.0g/kg, wherein A1 groups gavage 1.0g/kg tobacco protein, and A2 groups gavage 1.0g/kg is purple to bore
Chrysanthemum polysaccharide, the tobacco protein and 0.8g/kg Echinacea polysaccharide of A3 group gavages 0.2g/kg, the tobacco protein of A4 group gavages 0.5g/kg
With 0.5g/kg Echinacea polysaccharide, the tobacco protein and 0.25g/kg Echinacea polysaccharide, blank group and mould of A5 group gavages 0.75g/kg
Type group equal-volume normal saline solution gastric infusion;Simultaneously model group and medicine group A1-A5 press 100mgkg for administration-1Modeling
Dosage nape part hypodermic injection D- galactolipins, continuous 6 weeks., with equal-volume physiological saline, gavage is with injection simultaneously for blank group
Carry out, testing fatigue is carried out after continuous 42d.
2. mouse fatigue experiment and result
After mouse stomach modeling 6 weeks, transfer rod instrument fatigue experiment is carried out, mouse is placed on into transfer rod(Transfer rod diameter 30mm, length
60mm)On, rotating speed is 10rmin-1, every mouse is respectively trained 5min so as to adapt to the rotation in transfer rod.Next day, by mouse
It is placed on transfer rod, rotating speed is adjusted to 30rmin-1, the time of staying of the accurate recording mouse on transfer rod, maximum duration is limited to
10min, more than 10min 10min is then designated as, front with 70% ethanol transfer rod and miscellaneous part per batch test.
Compare with blank group, D- galactolipin modeling mouse agings substantially shorten in the transfer rod time of staying, and medicine group A1-
A5 can increase mouse aging muscle power, wherein A5 groups best results, and the difference between each experimental group is statistically significant, tool
Body the results are shown in Table 1.
Impact of the nutritious supplementary pharmaceutical of the present invention of table 1 to mouse time of staying on transfer rod fatigue instrument
3. mouse fatigue related biochemical indicator is determined and result
Administration weighs Mouse Weight after terminating, and carries out eye socket blood sampling, 4000rmin-1It is to be measured serum to be collected after centrifugation 10min.
The method that the Biochemical Indexes such as BUN, MDA, NO, NOS are provided using related kit in serum, in strict accordance with kit
Illustrate to be operated, determine each biochemical indicator numerical value.
Compare with blank group, BUN, MDA, NO and NOS content is dramatically increased in D- galactolipin modeling mouse aging serum, and
Medicine group A1-A5 significantly reduces above-mentioned biochemical indicator content, wherein A5 groups best results, and specific experiment the results are shown in Table 2.
The nutritious supplementary pharmaceutical of the present invention of table 2 is to the tired impact with anti-oxidant related biochemical indicator in mice serum
4. conclusion
As a result prove, pharmaceutical composition of the present invention can reduce the content of BUN, MDA, NO and NOS in mice serum, pointing out should
Pharmaceutical composition can improve the oxidation resistance of body, remove cylinder super-oxidation lipid, reduce D- galactolipins and cause aging course
In elevated NO and NOS contents, increase caused cytotoxicity so as to mitigate NO, play a part of anti-aging.
Particularly in the case where active component total amount keeps constant, using the present invention containing tobacco protein and Echinacea polysaccharide
Nutritious supplementary pharmaceutical it is bright compared with the replenishers containing tobacco protein or Echinacea polysaccharide, each biochemical indicator content of mice plasma is used alone
It is aobvious to reduce, it was demonstrated that tobacco protein and being applied in combination for Echinacea polysaccharide generate synergy, reduce the use of active component
Amount.Wherein tobacco protein and many sugar weight ratios of Echinacea are 3:1 nutritious supplementary pharmaceutical effect is projected the most, is generated and is difficult to be expected
Excellent effect.
Claims (7)
1. a kind of nutritious supplementary pharmaceutical of anti-aging, it is characterised in that the active component of anti-aging is by tobacco egg in replenishers
It is 80-20% that white and Echinacea polysaccharide composition, wherein tobacco protein account for the percentage by weight of active component, and Echinacea polysaccharide accounts for work
Property composition percentage by weight be 20-80%.
2. nutritious supplementary pharmaceutical according to claim 1, it is characterised in that tobacco protein accounts for the percentage by weight of active component
For 80-50%, it is 20-50% that Echinacea polysaccharide accounts for the percentage by weight of active component.
3. nutritious supplementary pharmaceutical according to claim 2, it is characterised in that tobacco protein and Echinacea polysaccharide account for active component
Percentage by weight be respectively 75% and 25%.
4. nutritious supplementary pharmaceutical according to claim 1, it is characterised in that the nutritious supplementary pharmaceutical further includes food
Or acceptable additive on health products.
5. nutritious supplementary pharmaceutical according to claim 4, it is characterised in that acceptable additive is selected from anti-on the food
One or more in rotten agent, thickener and flavor enhancement etc..
6. nutritious supplementary pharmaceutical according to claim 5, it is characterised in that the preservative is benzoic acid;Thickener is fruit
Glue or gelatin, preferably pectin;Flavor enhancement is Aspartame.
7. application of the nutritious supplementary pharmaceutical described in any one of claim 1-6 in the food or health products for preparing anti-aging.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611177806.3A CN106617106A (en) | 2016-12-19 | 2016-12-19 | Nutritional supplement capable of delaying senescence |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611177806.3A CN106617106A (en) | 2016-12-19 | 2016-12-19 | Nutritional supplement capable of delaying senescence |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106617106A true CN106617106A (en) | 2017-05-10 |
Family
ID=58833298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611177806.3A Pending CN106617106A (en) | 2016-12-19 | 2016-12-19 | Nutritional supplement capable of delaying senescence |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106617106A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114409816A (en) * | 2021-12-20 | 2022-04-29 | 天津科技大学 | Chicory root polysaccharide, extraction method thereof and preparation method of blood sugar reducing beverage containing chicory root polysaccharide |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102100715A (en) * | 2009-12-16 | 2011-06-22 | 青岛康地恩药业有限公司 | Preparation of powder and injection preparations of echinacea purpurea polysaccharides |
-
2016
- 2016-12-19 CN CN201611177806.3A patent/CN106617106A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102100715A (en) * | 2009-12-16 | 2011-06-22 | 青岛康地恩药业有限公司 | Preparation of powder and injection preparations of echinacea purpurea polysaccharides |
Non-Patent Citations (4)
Title |
---|
徐歆: "紫锥菊提取物对小鼠免疫和抗沙门氏菌感染能力的影响及其机理研究", 《中国博士学位论文全文数据库 农业科技辑》 * |
李立人,等: "烟草部份1蛋白结晶的三种简易制备方法", 《植物生理学报》 * |
赵谋明,等: "烟草蛋白质研究进展", 《烟草科技》 * |
钟琳: "青娥方提取物对D-半乳糖致衰老小鼠的延缓衰老作用及机制", 《中国实验方剂学杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114409816A (en) * | 2021-12-20 | 2022-04-29 | 天津科技大学 | Chicory root polysaccharide, extraction method thereof and preparation method of blood sugar reducing beverage containing chicory root polysaccharide |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sujatha et al. | Moringa oleifera–nature’s gold | |
Buhroo et al. | Trends in development and utilization of sericulture resources for diversification and value addition | |
JP2003510285A (en) | Echinacea supplement and method for producing the same | |
CN112273656A (en) | Black garlic oral liquid capable of enhancing immunity and preparation method thereof | |
KR20180118361A (en) | Method for manufacturing concentrate of Aronia | |
CN106617106A (en) | Nutritional supplement capable of delaying senescence | |
KR20100137100A (en) | Hang over beverage containing freeze-dring abalone flesh and it's manufacturing method | |
WO2007007994A1 (en) | Food composition for improving liver function comprising a lonicera caerulea l. var. edulis extract | |
CN110731362A (en) | kinds of low-sugar high-protein high-nutrition biscuits and preparation method thereof | |
KR20120095595A (en) | Method of preparing fattune liquid comprising onion and grapefruit | |
KR101768612B1 (en) | Food composition for improving liver function and method of health tea using thereof | |
KR102347923B1 (en) | Extract of chicken comprising ginseng and preparation method of thereof | |
TW200948371A (en) | Cultivation method and liquid culture medium for cultivation of mycelium and fruiting body of Cordyceps | |
KR102198517B1 (en) | Cereal products for improving low weight with leafs from herb and mushroom | |
CN106722926A (en) | A kind of preparation method of honey rose cream processed | |
KR101111288B1 (en) | Functional red pepper paste and manufacturing method thereof | |
KR100842807B1 (en) | Preparation method for deoduk-white kimchi using korean cabbage & codonopsis lanceolata | |
KR101701809B1 (en) | Red ginseng milk beverage containing black garlic and method for preparing thereof | |
KR20150074683A (en) | method manufacturing Powder of Cudrania tricuspidata | |
KR101514614B1 (en) | Dendropanax morbifera Lev. cheese and process for preparing the same | |
KR101493442B1 (en) | The extracts concentrate of medical herbs for promoting children and youths growth and method for fabricating the same | |
JPH10158187A (en) | Medicine/food composition | |
KR101164791B1 (en) | Method for production of ginseng or red ginseng extracts using makgeolli | |
CN106262620A (en) | A kind of preparation method of natural aromatic condiment | |
KR102181437B1 (en) | Manufacturing method of stir-fried ssamjang using anti-bacterial plant compound red pepper paste |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170510 |
|
RJ01 | Rejection of invention patent application after publication |